#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Familial haemophagocytic lymphohistiocytosis Orthostatic hypotension Propionic acidaemia Amyotrophic lateral sclerosis Follicle centre lymphoma follicular grade I, II – III Pseudomyxoma peritonei Synovial sarcoma Alport's syndrome Polycystic liver disease Congenital megacolon Pleural mesothelioma malignant Glioblastoma multiforme Glycogen storage disease type II Chondrodystrophy Non-small cell lung cancer More trials…

    Learn about Rare Diseases

    Mastocytosis – Trials in Disease Congenital nephrogenic diabetes insipidus – Trials in Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Diagnostics Lysosomal storage disorder – Trials in Disease Antithrombin III deficiency – Life with Disease Erdheim-Chester disease – Diagnostics Hereditary hypophosphataemic rickets Kearns-Sayre syndrome – Life with Disease Idiopathic pulmonary fibrosis Hypereosinophilic syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mebufotenin Exidavnemab Divarasib Hexaminolevulinate Pegipanermin Selpercatinib RNMB2 Naloxegol Oxalate Anastrozole 99MTC-EUK-(SO3)CY5-MAS3 Thiamine Hydrochloride Trehalose Dihydrate (Ph.eur.) Filgrastim Asparaginase Temozolomide Leflunomide Cortisone Acetate Bezafibrate Sot102 Hu5F9‐G4 More therapies…

    Learn about Your Condition

    Epithelioid sarcoma Neuropathic arthropathy Premature baby Chronic hepatitis C Ejection fraction normal Mixed dementia Ewing's sarcoma Femoral hernia Vertebrobasilar stroke Rectal cancer stage II Acute myeloid leukaemia Osteopenia Carpal tunnel syndrome Myeloproliferative neoplasm Tendon injury More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of EXL-01 and Nivolumab for Patients with Advanced Non-Small Cell Lung Cancer Resistant to Immunotherapy

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Exl01
    • Nivolumab
    France

  • Study on Treating Anemia After Cesarean with Ferric Carboxymaltose or Oral Iron in Women with Moderate Iron Deficiency Anemia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dried Ferrous Sulfate
    • Ferric Carboxymaltose
    • Ferrous Sulfate
    France

  • Study on Graft-Versus-Host Disease Prevention Using Cyclophosphamide and Methotrexate in Adults with Blood Cancer Undergoing Matched-Donor Transplant

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Graft versus host disease
    Investigated Drugs:
    • Anti-Human T-Lymphocyte Immunoglobulin From Rabbits
    • Clofarabine
    • Thiotepa
    France

  • Study on Vagus Nerve Stimulation and Sodium Oxybate for Patients with Cerebral Amyloid Angiopathy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cerebral amyloid angiopathy
    Investigated Drugs:
    • Sodium Oxybate
    The Netherlands

  • Study on Long-Term Safety of Enzalutamide, Abiraterone, and Prednisolone for Patients with Prostate Cancer from Previous Enzalutamide Trials

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    Investigated Drugs:
    • Abiraterone
    • Enzalutamide
    • Prednisolone
    Austria Belgium Czechia Denmark Finland France +9

  • Study of controlled-release nicotinamide (CICR-NAM) tablets for treating mild to moderate ulcerative colitis

    Recruiting

    4 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Nicotinamide
    Germany
Previous Page
1 … 463 464 465 466 467 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!